PRAVASTATIN SODIUM
- Product NDC
- 70934-236
- 11-digit product format
- 709340236
- Labeler code
- 70934
- Product ID
- 70934-236_b7c3d7b7-a21b-4830-e053-2995a90a3a7f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PRAVASTATIN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA207068
- Marketing category
- ANDA
- Marketing start
- 2019-01-09
- Marketing end
- 0000-00-00
- Substance
- PRAVASTATIN SODIUM
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-236-30 | PRAVASTATIN SODIUM | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-236 | PRAVASTATIN SODIUM TABLET [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC, 1 package rows | 20210105_87fcfa73-cc3a-b318-e053-2995a90a3a79.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-236-30 | 70934023630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-236-30) | 30 tablet | 2019-01-09 | 0000-00-00 | No | No | Current |